Protective efficacy of virus-like particles for bluetongue disease.
about
Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Multigene expression of protein complexes by iterative modification of genomic Bacmid DNAProducing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.Subviral particle as vaccine and vaccine platform.Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.Use of the baculovirus expression system for the generation of virus-like particles.Oncolytic bluetongue viruses: promise, progress, and perspectivesIn vitro reconstitution of Bluetongue virus infectious cores.Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particlesProspects for improved bluetongue vaccines.Bluetongue vaccines: the past, present and future.Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.Virus-like particle vaccines and adjuvants: the HPV paradigm.Bluetongue vaccines in Europe.Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.Genetically engineered multi-component virus-like particles as veterinary vaccines.Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.Vaccines for bluetongue.Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles.Opinion of the Scientific Panel on Animal Health an Welfare (AHAW) on the EFSA Selfmandate on bluetongue origin and occurrenceBluetongue vaccination in Europe
P2860
Q30242080-EC0A7977-B23E-4825-A383-1A7A42E319BBQ33499534-C75A9B09-4D6B-485A-A716-6D22B1C90A58Q33690975-3CE00AB7-84E8-4467-B3D0-DA61AF6E2C8BQ33812653-22A39E0B-02C4-4D93-BAAA-D695792633BDQ34204054-69E6F503-20B6-46A6-A8A4-EA815D100998Q34351909-E8D43D6F-1B80-4E45-9DF8-53557D118741Q35084491-1BB934B5-2672-4822-B12D-0BFED4A8E338Q35170961-CA9C1E69-9726-4556-B5BA-EA1C8C39E3FCQ36685977-51447A0A-5C56-46EA-802A-9C6CFA01DF41Q37369882-AA28CBB4-19D7-47B9-9D76-43929D22D2DAQ37386291-3A6F374D-8131-4598-B4D9-5EF4F23EF8F8Q37512822-83AA0EFD-0A61-4D6C-A696-629CB5FE9F98Q37608311-808F19EA-48BE-4EE3-9803-894D32149479Q37896583-3DE73454-F5EF-46FE-8FEA-AD8512EB8433Q39272520-158E2365-38E5-410E-8CC9-7FB49B4D3881Q40405794-2E22F996-81BC-40F8-BEA9-922F5066F371Q40795529-3889C97F-38BE-4DF5-9306-7D053E1290AEQ41183186-42FDEE5A-0097-4892-B804-BDCD5E1BEC6CQ41190029-75539963-E96B-47CE-A9DE-97B4FE9AE265Q41877558-97289F01-2331-41D5-BA76-522B43165E67Q43415758-123E1466-828D-47C9-80B0-A249FED3B083Q47144792-D6F5251A-DEBD-41D3-82D7-22F1B3DE0621Q56993017-5C078FE9-F485-473E-BD34-D113F84AAD2E
P2860
Protective efficacy of virus-like particles for bluetongue disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Protective efficacy of virus-like particles for bluetongue disease.
@en
Protective efficacy of virus-like particles for bluetongue disease.
@nl
type
label
Protective efficacy of virus-like particles for bluetongue disease.
@en
Protective efficacy of virus-like particles for bluetongue disease.
@nl
prefLabel
Protective efficacy of virus-like particles for bluetongue disease.
@en
Protective efficacy of virus-like particles for bluetongue disease.
@nl
P2093
P1433
P1476
Protective efficacy of virus-like particles for bluetongue disease.
@en
P2093
P356
10.1016/0264-410X(92)90415-G
P407
P577
1992-01-01T00:00:00Z